Vote in the European Parliament

Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795

Date: 20.01.2026·Reference: A10-0272/2025
Rapporteur: Tomislav Sokol

Overall Result

  • 503 For
  • 57 Against
  • 108 Abstention
  • 51 Did not vote

Status

Adopted

Outcome as recorded by the European Parliament.

Vote held on

Procedure timeline

No procedure timeline is available for this vote yet.

Sources

Data: EP Open Data API

What is this about?

  • This regulation seeks to enhance the security of supply and availability of critical medicines across the EU.
  • It establishes a framework to diversify supply chains and incentivize investments in local manufacturing capacities.
  • Special focus is placed on older, off-patent drugs through targeted financial support and streamlined approval processes.
  • Coordination among member states aims to reduce market fragmentation and strengthen the internal market.
  • The goal is to bolster the EU’s strategic autonomy in the healthcare sector.
Source: Explanatory Statement (AI Generated)

Vote by political group

How the political groups voted

Members

Showing 10 of 719

Vote Position
NameCountryGroupVote Position
BulgariaEPP
For
ItalyS&D
For
RomaniaS&D
For
SwedenGUE/NGL
For
FranceRenew
For
FranceEPP
For
CzechiaEPP
For
IrelandS&D
For
DenmarkEPP
For
EstoniaRenew
For
Show more
Follow us on Instagram@checksomevotes@checksomevotes_en